SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Sophiris Bio, Inc. (SPHS)

Add SPHS Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 5/23/2017 4:48:45 PM - Followers: 126 - Board type: Free - Posts Today: 0

Sophiris Bio Inc.

Sophiris Bio Inc. is a Canadian urology company with operations based in San Diego developing a late-stage, highly targeted treatment for benign prostatic hyperplasia (BPH or enlarged prostate), a large unsatisfied market. PRX302, the company’s lead candidate for BPH, is designed to be as efficacious as pharmaceuticals, less invasive than the surgical interventions, and without the sexual side effects seen with existing treatments. Sophiris is planning to begin a pivotal trial by the end of 2012.

The pivotal trial is supported by a randomized, controlled Phase IIb study that met the objective and subjective endpoints used as the basis for current BPH drug approvals. Sophiris is advised by world-leading urologists, is backed by experienced investors, and is led by an experienced drug development team that has achieved more than twenty drug approvals including several blockbusters.


Ongoing Clinical Development
Study Phase Trial Design
PRX302-3-01 BPH


III On-going/Enrollment Completed (479 patients) Prospective, randomized, double-blind, placebo-controlled, transrectal treatment of PRX302, which will utilize the IPSS outcome measure evaluated at 12 months as the primary endpoint
PRX302-2-7 PCa


IIa Enrolling (approximately 20 patients) Open label, Phase 2a study, evaluating the safety and tolerability of targeted intraprostatic administration of PRX302 to treat men with histologically proven, clinically significant, localized, low to intermediate risk prostate cancer

Completed Clinical Development

Study Phase
(pts treated with PRX302
Trial Design
PRX302-2-03 BPH
IIb (61 pts) Randomized, double-blind, placebo-controlled, transperineal treatment of PRX302
PRX302-2-06 BPH I/II (32 pts) Randomized dose escalation, multicenter trial of a single transrectal intraprostatic treatment of PRX302
Phase 2a BPH
IIa (18 pts) Open-label, safety, volume escalation clinical trial of a single transperineal treatment of PRX302
I (15 pts) Open-label, safety, dose escalation clinical trial of a signal transperineal intraprostatic treatment of PRX302
PRX302 PCa I (24 pts) Open-label, safety and tolerability, dose escalation trial of PRX302 in patients with biopsy-proven, locally-recurrent prostate cancer
PRX302 PCa II (6 pts) Open-label clinical trial in locally-recurrent prostate cancer

$SPHS was $40.00 in 2011 We will be back there soon enough.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
SPHS News: Sophiris Bio Provides Update on Phase 2b Study of Topsalysin in Localized Prostate Cancer 05/23/2017 04:05:00 PM
SPHS News: Quarterly Report (10-q) 05/15/2017 05:42:49 PM
SPHS News: Current Report Filing (8-k) 05/15/2017 04:42:48 PM
SPHS News: Sophiris Bio Reports First Quarter Financial Results and Key Corporate Highlights 05/15/2017 04:05:00 PM
SPHS News: Sophiris Bio Presents Topsalysin Data from Phase 2a Proof-of-Concept Study in Localized Prostate Cancer at 112th American Uro... 05/15/2017 07:00:00 AM
#2763   Yes this is great news now we should nymostwanted 05/23/17 04:48:45 PM
#2762   AH NEWS Awl416 05/23/17 04:21:06 PM
#2761   Where is the partnership announce it already let's nymostwanted 05/16/17 11:33:43 AM
#2760   .06 jump after hours to return to 2.65 AprilFool 05/15/17 05:25:16 PM
#2759   Important updated info: melaurian 05/12/17 09:05:53 AM
#2758   Waiting on the next good thing .. nymostwanted 05/07/17 03:59:38 PM
#2757   We are in both, currently very + with each. north40000 04/04/17 09:00:57 PM
#2756   I let you know when I buy back nymostwanted 04/03/17 07:11:25 PM
#2755   Lots more risk in this one IMO. But Lnp30 04/03/17 06:19:06 PM
#2754   Too much positive data here and lots of nymostwanted 04/03/17 05:45:43 PM
#2753   Not too too late to turn back! Lnp30 04/01/17 09:09:47 PM
#2752   We just need some good volume and we nymostwanted 04/01/17 01:14:02 PM
#2751   SPHS bullish 2.7800 stocktrademan 03/28/17 04:18:57 PM
#2750   Updated PRX302 PC Ph2a Results Abstract Poster djpope 03/27/17 01:02:53 AM
#2749   They said they won't be using cash from nymostwanted 03/26/17 05:25:56 PM
#2748   don't they need to raise cash soon? Any StocksInvestor 03/26/17 05:21:59 PM
#2747   Need to break $3.25 to confirm a higher nymostwanted 03/25/17 05:53:55 PM
#2746   Topsalysin Data from Successful Phase 2a Localized Prostate AprilFool 03/23/17 05:04:54 PM
#2745   Great news, let's go mike007 03/23/17 04:29:15 PM
#2744   Where is our 10Q !!! Let's go .. Gremlins 03/21/17 05:11:19 PM
#2743   Be careful today shorts;) nymostwanted 03/16/17 09:34:57 AM
#2742   check AVIR it went up on Friday from pad72m 03/13/17 01:15:44 PM
#2741   SPHS News Views and Commentary updated: melaurian 02/25/17 06:42:31 PM
#2740   38 Mil shares fully diluted. Bullish Betz 02/20/17 06:42:14 AM
#2739   It went to 8 on news. What news K-Pax 02/16/17 09:47:06 AM
#2738   He's not far off. What do we have Lnp30 02/15/17 11:59:42 AM
#2737   I dunno why it went to $8 before? nymostwanted 02/15/17 09:46:02 AM
#2736   $10-15 based on what? K-Pax 02/15/17 08:26:02 AM
#2735   Thanks & you are very Welcome djpope 02/14/17 08:23:05 PM
#2734   You on top of your game, I never nymostwanted 02/14/17 08:07:07 PM
#2733   Yes share price held steady for 6 months djpope 02/14/17 07:46:54 PM
#2732   I see a stock that's being held steady nymostwanted 02/14/17 07:09:02 PM
#2731   What is it that you think you see? djpope 02/14/17 07:05:16 PM
#2730   If no one can see what's happening here nymostwanted 02/14/17 05:46:28 PM
#2729   Wow how many more 13d and b's this nymostwanted 02/14/17 04:39:37 PM
#2728   14d-9 not filed because there is no offer nymostwanted 02/14/17 12:01:13 AM
#2727   When did they file 14D-9. Can't find date flm09 02/13/17 11:22:18 AM
#2726   Thank you. Stock price shows that , I selinpinar 02/08/17 11:10:05 AM
#2725   No same presentation. Nothing new nymostwanted 02/08/17 10:45:03 AM
#2724   What did he say?? Anything interesting?? selinpinar 02/08/17 10:44:10 AM
#2723   SAN DIEGO and VANCOUVER, British Columbia , Jan. nymostwanted 02/01/17 11:02:54 PM
#2722   SAN DIEGO and VANCOUVER, British Columbia, Jan. 30, ElisComing 02/01/17 08:50:39 PM
#2721   SAN DIEGO and VANCOUVER, British Columbia, May 12, nymostwanted 01/30/17 02:51:54 PM
#2720   All these 13G filing hmm disclosure of voting nymostwanted 01/30/17 02:51:18 PM
#2719   February 9th should get a quarter report .. nymostwanted 01/25/17 10:55:52 PM
#2718   Back to where this was before the big EasyRider 01/19/17 08:10:09 PM
#2717   Sure looked like another institution loaded up today. pgh_maulers 01/18/17 09:20:33 PM
#2716   Form 4's in December pgh_maulers 01/18/17 08:42:11 PM
#2715   SAN DIEGO and VANCOUVER, British Columbia, May 12, nymostwanted 01/17/17 10:23:09 PM
#2714   How can anyone know? pgh_maulers 01/17/17 05:46:32 PM